Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics ; volume:10 ; number:4 ; day:12 ; month:6 ; year:2020 ; pages:615-621 ; date:8.2020
Dermatology and therapy ; 10, Heft 4 (12.6.2020), 615-621, 8.2020
- Creator
-
Menter, Alan
Armstrong, April
Voorhees, Abby Van
Liu, Clive
Jacobson, Abby
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-020-00411-w
- URN
-
urn:nbn:de:101:1-2020091519493234594858
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Menter, Alan
- Armstrong, April
- Voorhees, Abby Van
- Liu, Clive
- Jacobson, Abby
- SpringerLink (Online service)
Other Objects (12)
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Adverse reactions to biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry
Biologics in Prevention of Psoriasis to Psoriatic Arthritis Transition: The Need of Prospective Analyses and Stratification According to Time-Related Risk Factors
Safety of treatment with biologics for psoriasis in daily practice: 5-year data
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Adverse reactions to biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry
Biologics in Prevention of Psoriasis to Psoriatic Arthritis Transition: The Need of Prospective Analyses and Stratification According to Time-Related Risk Factors
Safety of treatment with biologics for psoriasis in daily practice: 5-year data
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Adverse reactions to biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry
Biologics in Prevention of Psoriasis to Psoriatic Arthritis Transition: The Need of Prospective Analyses and Stratification According to Time-Related Risk Factors